Drugs for Kidney Cancer (Renal-Cell Carcinoma)

Table. Drugs Prescribed for Kidney (Renal-Cell) Cancer

• Drug name (generic name)
• Drug company
• Indications
• Patient support services

Drug name (generic name)
• Afinitor (everolimus) Tablets
Drug company
• Novartis
Indication
• Treatment of advanced renal-cell carcinoma
Patient support services
• Novartis Oncology Universal Co-pay Program
  877-577-7756
  
  Novartis Patient Assistance Foundation
  800-277-2254

Drug name (generic name)
• Avastin (bevacizumab) Injection
Drug company
• Genentech
Indication
• Treatment of metastatic renal-cell carcinoma
Patient support services
• Genentech Oncology Co-pay Assistance Program
  855-692-6729
  
  Genentech Patient Foundation
  888-941-3331

Drug name (generic name)
• Bavencio (avelumab)
Drug company
• EMD Serono
Indication
• First-line treatment of advanced renal-cell carcinoma, in combination with axitinib
Patient support services
• CoverOne Co-Pay Assistance Program
  844-826-8371
  
  CoverOne Patient Assistance Program
  844-826-8371

Drug name (generic name)
• Cabometyx (cabozantinib) Tablets
Drug company
• Exelixis
Indication
• Treatment of advanced renal-cell carcinoma
  
  First-line treatment, in combination with Opdivo, of patients with advanced renal-cell carcinoma
Patient support services
• EASE Co-pay Program
  844-900-3273
  
  EASE Patient Assistance Program
  844-900-3273

Drug name (generic name)
• Fotivda (tivozanib) Capsules
Drug company
• AVEO Pharmaceuticals
Indication
• Treatment of relapsed or refractory renal-cell carcinoma after 2 or more previous therapies
Patient support services
• AVEO ACE Co-pay Assistance Program
  833-368-4832
  
  AVEO ACE Patient Assistance Program
  833-368-4832

Drug name (generic name)
• Inlyta (axitinib) Tablets
Drug company
• Pfizer
Indication
• Treatment of advanced renal-cell carcinoma
Patient support services
• Pfizer Oncology Together Co-Pay Savings Program
  877-744-5675
  
  Pfizer Patient Assistance Program
  877-744-5675

Drug name (generic name)
• Keytruda (pembrolizumab)
Drug company
• Merck
Indication
• First-line treatment of advanced renal-cell carcinoma, in combination with axitinib
  
  First-line treatment, in combination with Lenvima, of adults with advanced renal-cell carcinoma
  
  Adjuvant (additional) treatment of patients with renal-cell carcinoma at intermediate-high or high risk of recurrence after nephrectomy, or after nephrectomy and resection of metastatic lesions
Patient support services
• Merck Co-Pay Assistance Program
  855-257-3932
  
  Merck Patient Assistance Program
  855-257-3932

Drug name (generic name)
• Lenvima (lenvatinib) Capsules
Drug company
• Eisai
Indication
• Treatment of advanced renal-cell carcinoma
  
  First-line treatment, in combination with Keytruda, of adults with advanced renal-cell carcinoma
Patient support services
• Lenvima $0 Co-Pay Program
  866-613-4724
  
  Lenvima Patient Assistance Program
  866-613-4724

Drug name (generic name)
• Mvasi (bevacizumabawwb)
Drug company
• Amgen
Indication
• Treatment of metastatic renal-cell carcinoma, in combination with interferon-alfa
Patient support services
• Amgen FIRST STEP Co-Pay Program
  866-264-2778
  
  Amgen Safety Net Foundation
  866-264-2778

Drug name (generic name)
• Nexavar (sorafenib) Tablets
Drug company
• Bayer
Indication
• Treatment of advanced renal-cell carcinoma
Patient support services
• Nexavar $0 Co-Pay Program
  866-581-4992
  
  Bayer US Patient Assistance Foundation
  866-228-7723

Drug name (generic name)
• Opdivo (nivolumab)
Drug company
• Bristol Myers Squibb
Indication
• Treatment of advanced renal-cell carcinoma
  
  Untreated, intermediateor poor-risk advanced renal-cell carcinoma, in combination with Yervoy
  
  First-line treatment, in combination with Cabometyx, of patients with advanced renal-cell carcinoma
Patient support services
• BMS Oncology Co‑Pay Assistance Program
  800-861-0048
  
  Bristol Myers Squibb Patient Assistance Foundation
  800-736-0003

Drug name (generic name)
• Sutent (sunitinib malate) Capsules
Drug company
• Pfizer
Indication
• Treatment of advanced renal-cell carcinoma
Patient support services
• Pfizer Oncology Together Co-Pay Savings Program
  877-744-5675
  
  Pfizer Patient Assistance Program
  877-744-5675

Drug name (generic name)
• Torisel (temsirolimus)
Drug company
• Pfizer
Indication
• Treatment of advanced renal-cell carcinoma
Patient support services
• Pfizer Patient Assistance Program
  877-744-5675

Drug name (generic name)
• Votrient (pazopanib) Tablets
Drug company
• Novartis
Indication
• Treatment of advanced renal-cell carcinoma
Patient support services
• Novartis Oncology Universal Co-Pay Program
  877-577-7756
  
  Novartis Patient Assistance Foundation
  800-277-2254

Drug name (generic name)
• Welireg (belzutifan) Tablets
Drug company
• Merck
Indication
• Treatment of adults with von Hippel-Lindau disease and renal-cell carcinoma not requiring surgery
Patient support services
• Merck Co-Pay Coupon
  855-257-3932
  
  Merck Patient Assistance Program
  855-257-3932

Drug name (generic name)
• Yervoy (ipilimumab)
Drug company
• Bristol Myers Squibb
Indication
• Treatment of patients with untreated, intermediate- or poorrisk advanced renal-cell carcinoma, in combination with Opdivo
Patient support services
• BMS Oncology Co-pay Assistance Program
  800-861-0048
  
  Bristol Myers Squibb Patient Assistance Foundation
  800-736-0003

Drug name (generic name)
• Zirabev (bevacizumab-bvzr)
Drug company
• Pfizer
Indication
• Treatment, in combination with interferon-alfa, of metastatic renal-cell carcinoma
Patient support services
• Pfizer Oncology Together Co-Pay Savings Program
  877-744-5675
  
  Pfizer Patient Assistance Program
  877-744-5675